Effects of lisuride hydrogen maleate on pericontusional tissue metabolism, brain edema formation, and contusion volume development after experimental traumatic brain injury in rats

Neuroscience Letters

Volumn 499, Issue 3, 2011, Pages 189-193

  Zweckberger, K ^a   Simunovic, F ^a   Kiening, K L ^a   Unterberg, A W ^a   Sakowitz, O W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cerebral microdialysis; Controlled cortical impact injury (CCI); Dopamine; Lisuride; Secondary brain damage; Traumatic brain injury (TBI)

Indexed keywords

GLUCOSE; GLUTAMIC ACID; LACTIC ACID; LISURIDE MALEATE; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CONTUSION; BRAIN EDEMA; BRAIN WATER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE COMPARISON; MALE; MICRODIALYSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE METABOLISM; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN EDEMA; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GLUTAMIC ACID; LACTIC ACID; LISURIDE; MALE; MICRODIALYSIS; NEUROPROTECTIVE AGENTS; PYRUVIC ACID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79960099092     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.05.059     Document Type: Article

References (36)

1. Beaumont A., Hayasaki K., Marmarou A., Barzo P., Fatouros P., Corwin F. The effects of dopamine on edema formation in two models of traumatic brain injury. Acta Neurochir. Suppl. 2000, 76:147-151.
2. Beaumont A., Hayasaki K., Marmarou A., Barzo P., Fatouros P., Corwin F. Contrasting effects of dopamine therapy in experimental brain injury. J. Neurotrauma 2001, 18:1359-1372.
3. Byrnes K.R., Stoica B., Loane D.J., Riccio A., Davis M.I., Faden A.I. Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 2009, 57:550-560.
4. Caldwell M.A., Reymann J.M., Bentue-Ferrer D., Allain H., Leonard B.E. The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat. Neuropsychobiology 1996, 34:117-124.
5. Capria A., Attanasio A., Quatrana M., Cannata D., Fioravanti M., Stocchi F., Ruggieri S. Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease. Clin. Neuropharmacol. 1989, 12:331-338.
6. DeVito W.J., Avakian C., Stone S., Okulicz W.C., Tang K.T., Shamgochian M. Prolactin induced expression of interleukin-1 alpha, tumor necrosis factor-alpha, and transforming growth factor-alpha in cultured astrocytes. J. Cell. Biochem. 1995, 57:290-298.
7. DeVito W.J., Stone S., Shamgochian M. Prolactin induced expression of glial fibrillary acidic protein and tumor necrosis factor-alpha at a wound site in the rat brain. Mol. Cell. Endocrinol. 1995, 108:125-130.
8. Dixon C.E., Kraus M.F., Kline A.E., Ma X., Yan H.Q., Griffith R.G., Wolfson B.M., Marion D.W. Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats. Restor. Neurol. Neurosci. 1999, 14:285-294.
9. Goodman J.C., Valadka A.B., Gopinath S.P., Uzura M., Robertson C.S. Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis. Crit. Care Med. 1999, 27:1965-1973.
10. Hirata H., Ogawa N., Haba K., Asanuma M., Chou H., Mori A. Effects of chronic administration of lisuride hydrogen maleate on aromatic amine and metabolite levels in the gerbil brain following bilateral common carotid ligation. Arch. Int. Pharmacodyn. Ther. 1992, 315:5-15.
11. Kline A.E., Chen M.J., Tso-Olivas D.Y., Feeney D.M. Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function. Pharmacol. Biochem. Behav. 1994, 48:773-779.
12. Kline A.E., Massucci J.L., Ma X., Zafonte R.D., Dixon C.E. Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma. J. Neurotrauma 2004, 21:1712-1722.
13. Kline A.E., Massucci J.L., Marion D.W., Dixon C.E. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J. Neurotrauma 2002, 19:415-425.
14. Kline A.E., Yan H.Q., Bao J., Marion D.W., Dixon C.E. Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci. Lett. 2000, 280:163-166.
15. Kochanek P.M., Hendrich K.S., Dixon C.E., Schiding J.K., Williams D.S., Ho C. Cerebral blood flow at one year after controlled cortical impact in rats: assessment by magnetic resonance imaging. J. Neurotrauma 2002, 19:1029-1037.
16. Kotecha S.A., Oak J.N., Jackson M.F., Perez Y., Orser B.A., Van Tol H.H., MacDonald J.F. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 2002, 35:1111-1122.
17. Kroppenstedt S.N., Sakowitz O.W., Thomale U.W., Unterberg A.W., Stover J.F. Influence of norepinephrine and dopamine on cortical perfusion, EEG activity, extracellular glutamate, and brain edema in rats after controlled cortical impact injury. J. Neurotrauma 2002, 19:1421-1432.
18. Kroppenstedt S.N., Sakowitz O.W., Thomale U.W., Unterberg A.W., Stover J.F. Norepinephrine is superior to dopamine in increasing cortical perfusion following controlled cortical impact injury in rats. Acta Neurochir. Suppl. 2002, 81:225-227.
19. Kroppenstedt S.N., Stover J.F., Unterberg A.W. Effects of dopamine on posttraumatic cerebral blood flow, brain edema, and cerebrospinal fluid glutamate and hypoxanthine concentrations. Crit. Care Med. 2000, 28:3792-3798.
20. McAdoo D.J., Wu P. Microdialysis in central nervous system disorders and their treatment. Pharmacol. Biochem. Behav. 2008, 90:282-296.
21. Micieli G., Martignoni E., Cavallini A., Pacchetti C., Rossi F., Horowski R., Nappi G. Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects. Funct. Neurol. 1996, 11:317-325.
22. Miyazawa T., Murayama C., Nakagawa H. Effect of lisuride on experimental cerebral infarction in rats. Nippon Yakurigaku Zasshi 1991, 98:449-456.
23. Neumann-Haefelin T., Kastrup A., de Crespigny A., Yenari M.A., Ringer T., Sun G.H., Moseley M.E. Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke 2000, 31:1972-1973. 1965-1972 (discussion).
24. O'Neill M.J., Hicks C.A., Ward M.A., Cardwell G.P., Reymann J.M., Allain H., Bentue-Ferrer D. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. Eur. J. Pharmacol. 1998, 352:37-46.
25. Oddo M., Schmidt J.M., Carrera E., Badjatia N., Connolly E.S., Presciutti M., Ostapkovich N.D., Levine J.M., Le Roux P., Mayer S.A. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit. Care Med. 2008, 36:3233-3238.
26. Ogawa N., Haba K., Yoshikawa H., Kawata M., Sato H. Effects of lisuride hydrogen maleate on ischemia-induced depletion of brain acetylcholine levels in gerbils. Clin. Ther. 1989, 11:241-246.
27. Ohta K., Kuno S., Mizuta I., Fujinami A., Matsui H., Ohta M. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci. 2003, 73:617-626.
28. Olivecrona M., Rodling-Wahlstrom M., Naredi S., Koskinen L.O. Prostacyclin treatment in severe traumatic brain injury: a microdialysis and outcome study. J. Neurotrauma 2009, 26:1251-1262.
29. Schechter M.D. Evidence for a direct dopaminergic effect of lisuride. Pharmacol. Biochem. Behav. 1984, 21:185-189.
30. Suma T., Koshinaga M., Fukushima M., Kano T., Katayama Y. Effects of in situ administration of excitatory amino acid antagonists on rapid microglial and astroglial reactions in rat hippocampus following traumatic brain injury. Neurol. Res. 2008, 30:420-429.
31. Vespa P., Bergsneider M., Hattori N., Wu H.M., Huang S.C., Martin N.A., Glenn T.C., McArthur D.L., Hovda D.A. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J. Cereb. Blood Flow Metab. 2005, 25:763-774.
32. Yuen E.Y., Jiang Q., Chen P., Gu Z., Feng J., Yan Z. Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. J. Neurosci. 2005, 25:5488-5501.
33. Zweckberger K., Eros C., Zimmermann R., Kim S.W., Engel D., Plesnila N. Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice. J. Neurotrauma 2006, 23:1083-1093.
34. Zweckberger K., Simunovic F., Kiening K.L., Unterberg A.W., Sakowitz O.W. Anticonvulsive effects of the dopamine agonist lisuride maleate after experimental traumatic brain injury. Neurosci. Lett. 2010, 470:150-154.
35. Zweckberger K., Stoffel M., Baethmann A., Plesnila N. Effect of decompression craniotomy on increase of contusion volume and functional outcome after controlled cortical impact in mice. J. Neurotrauma 2003, 20:1307-1314.
36. Kroppenstedt S.N., Schneider G.H., Thomale U.W., Unterberg A.W. Protective effects of aptigalel (Crestat) following controlled cortical impact injury in the rat. J. Neurotrauma 1998, 15:1991-1997.